Apoptosis: A Target for Anticancer Therapy
AbstractApoptosis, the cell’s natural mechanism for death, is a promising target for anticancer therapy. Both the intrinsic and extrinsic pathways use caspases to carry out apoptosis through the cleavage of hundreds of proteins. In cancer, the apoptotic pathway is typically inhibited through a wide variety of means including overexpression of antiapoptotic proteins and under-expression of proapoptotic proteins. Many of these changes cause intrinsic resistance to the most common anticancer therapy, chemotherapy. Promising new anticancer therapies are plant-derived compounds that exhibit anticancer activity through activating the apoptotic pathway. View Full-Text
Share & Cite This Article
Pfeffer, C.M.; Singh, A.T.K. Apoptosis: A Target for Anticancer Therapy. Int. J. Mol. Sci. 2018, 19, 448.
Pfeffer CM, Singh ATK. Apoptosis: A Target for Anticancer Therapy. International Journal of Molecular Sciences. 2018; 19(2):448.Chicago/Turabian Style
Pfeffer, Claire M.; Singh, Amareshwar T.K. 2018. "Apoptosis: A Target for Anticancer Therapy." Int. J. Mol. Sci. 19, no. 2: 448.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.